The renal monoamine oxidases
- 1 January 1998
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 7 (1) , 33-36
- https://doi.org/10.1097/00041552-199801000-00006
Abstract
The mitochondrial enzyme monoamine oxidases A and B are among the major metabolic agents for the degradation of the biogenic amines adrenaline, noradrenaline, dopamine and serotonin. The fact that the kidney contains a large amount of monoamine oxidase suggests that the renal effects of biogenic amines might depend in part on the activity of these enzymes.Keywords
This publication has 29 references indexed in Scilit:
- Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistryNeuroscience, 1996
- Aggressive Behavior and Altered Amounts of Brain Serotonin and Norepinephrine in Mice Lacking MAOAScience, 1995
- Differential age-related changes of mao-a and mao-b in mouse brain and pe peripheral organsNeurobiology of Aging, 1994
- Abnormal Behavior Associated with a Point Mutation in the Structural Gene for Monoamine Oxidase AScience, 1993
- Type A and B monoamine oxidase activities in the human and rat kidneyActa Physiologica Scandinavica, 1992
- Human monoamine oxidase A and B genes exhibit identical exon-intron organization.Proceedings of the National Academy of Sciences, 1991
- New directions in monoamine oxidase A and B selective inhibitors and substratesBiochemical Pharmacology, 1991
- Evidence for an extraneuronal location of monoamine oxidase in renal tissuesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1990
- Biochemistry and genetics of monoamine oxidasePharmacology & Therapeutics, 1990
- cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.Proceedings of the National Academy of Sciences, 1988